Copyright
©The Author(s) 2021.
World J Gastroenterol. Feb 7, 2021; 27(5): 404-415
Published online Feb 7, 2021. doi: 10.3748/wjg.v27.i5.404
Published online Feb 7, 2021. doi: 10.3748/wjg.v27.i5.404
Table 3 Posttreatment predominantly progressive, indeterminate and predominately regressive score vs changes in Ishak stage to evaluate disease progression or regression (n = 23)
| Ishak (pre-post) | Posttreatment P-I-R score (n = 23) | ||
| Progressive (n = 5) | Indeterminate (n = 9) | Regressive (n = 9) | |
| Increase (n = 1) | Absolutely advancing 100% (1 of 1) | 0 | 0 |
| Stable (n = 18) | Probably advancing 22% (4 of 18) | 33% (6 of 18) | Probably reversing 44% (8 of 18) |
| Decrease (n = 4) | 0 | 75% (3 of 4) | Absolutely reversing 33% (1 of 3) |
- Citation: Huang R, Rao HY, Yang M, Gao YH, Wang J, Jin Q, Ma DL, Wei L. Histopathology and the predominantly progressive, indeterminate and predominately regressive score in hepatitis C virus patients after direct-acting antivirals therapy. World J Gastroenterol 2021; 27(5): 404-415
- URL: https://www.wjgnet.com/1007-9327/full/v27/i5/404.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i5.404